Literature DB >> 23887022

Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.

William J Savage1, Shirley Reddoch, Jaime Wolfe, James F Casella.   

Abstract

Iron overload is an inevitable consequence of chronic red cell transfusions without erythrocytapheresis or chelation therapy. The effectiveness of partial manual exchange, a technique used to slow iron loading, has not been evaluated. We evaluated all children with sickle cell disease (SCD) receiving chronic transfusion to identify chelation-naive subjects who had quantitative liver iron concentration (LIC) studies. Seventeen chelation-naive children with SCD received a median of 29 transfusions before first LIC determination. Serum ferritin concentrations were assessed before each transfusion. The mean volume of blood phlebotomized before each transfusion was 5.1±1.8 mL/kg, which cumulatively resulted in a calculated median of 35.0 mg/kg iron removal. Using linear regression, pretransfusion phlebotomy resulted in a statistically significant reduction in ferritin (-8.8 ng/mL of ferritin for each mg/kg of iron phlebotomized, P=0.02). A reduction in LIC from pretransfusion phlebotomy could not be established (P=0.4). Partial manual exchanges appear to be an effective strategy for slowing the pace of iron loading in the setting of chronic transfusion for SCD.

Entities:  

Mesh:

Year:  2013        PMID: 23887022      PMCID: PMC3753792          DOI: 10.1097/MPH.0b013e31829d470d

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  17 in total

1.  Hepatic iron concentration and total body iron stores in thalassemia major.

Authors:  E Angelucci; G M Brittenham; C E McLaren; M Ripalti; D Baronciani; C Giardini; M Galimberti; P Polchi; G Lucarelli
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

2.  Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload.

Authors:  S T Singer; K Quirolo; K Nishi; E Hackney-Stephens; C Evans; E P Vichinsky
Journal:  J Clin Apher       Date:  1999       Impact factor: 2.821

3.  Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.

Authors:  Ellen B Fung; Paul R Harmatz; Phillip D K Lee; Meredith Milet; Rita Bellevue; Michael R Jeng; Karen A Kalinyak; Mark Hudes; Suruchi Bhatia; Elliott P Vichinsky
Journal:  Br J Haematol       Date:  2006-10-10       Impact factor: 6.998

4.  Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Authors:  Robert J Adams; Donald Brambilla
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

Review 5.  Prospects for primary stroke prevention in children with sickle cell anaemia.

Authors:  Lori C Jordan; James F Casella; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

6.  Erythrocytapheresis limits iron accumulation in chronically transfused sickle cell patients.

Authors:  L M Hilliard; B F Williams; A E Lounsbury; T H Howard
Journal:  Am J Hematol       Date:  1998-09       Impact factor: 10.047

7.  Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

Authors:  D M Adams; W H Schultz; R E Ware; T R Kinney
Journal:  J Pediatr Hematol Oncol       Date:  1996-02       Impact factor: 1.289

8.  Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major.

Authors:  G M Brittenham; A R Cohen; C E McLaren; M B Martin; P M Griffith; A W Nienhuis; N S Young; C J Allen; D E Farrell; J W Harris
Journal:  Am J Hematol       Date:  1993-01       Impact factor: 10.047

9.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

10.  Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.

Authors:  H C Kim; N P Dugan; J H Silber; M B Martin; E Schwartz; K Ohene-Frempong; A R Cohen
Journal:  Blood       Date:  1994-02-15       Impact factor: 22.113

View more
  4 in total

1.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 2.  Sickle Cell Disease and Stroke: Diagnosis and Management.

Authors:  Courtney Lawrence; Jennifer Webb
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

Review 3.  How we manage iron overload in sickle cell patients.

Authors:  Thomas D Coates; John C Wood
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

4.  Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira - 2022.

Authors:  S R Loggetto; M P A Veríssimo; L G Darrigo-Junior; R Simões; W M Bernardo; J A P Braga
Journal:  Hematol Transfus Cell Ther       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.